340B Drug Pricing Program
A Bloomberg article published today (linked here and text below) discusses how the Department of Health and Human Services plans to “survey safety-net hospitals on the amount they pay for prescription drugs, following up on an effort to reduce the hospitals’ Medicare drug reimbursement during the…
For more than 30 years, thanks to bipartisan congressional support, the 340B program has helped eligible hospitals stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients and expand health services to the communities they serve.
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan. 1. The updated website includes a listing of the drug companies and drugs approved by HRSA for…
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan. 1, 2026.
The Senate Committee on Health, Education, Labor and Pensions today held a hearing discussing the 340B Drug Pricing Program and its growth and impacts on patients.
The Senate Committee on Health, Education, Labor and Pensions Oct. 23 held a hearing discussing the 340B program and its growth and impacts on patients.
AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and communities they serve.
The U.S. Senate Committee on Health, Education, Labor and Pensions Oct. 23 will hold a hearing titled, “The 340B Program: Examining Its Growth and Impact on Patients.”
Senate HELP Committee to hold hearing on 340B program
For nearly 30 years, the 340B Drug Pricing Program has provided financial help to safety-net hospitals to manage rising prescription drug costs. Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted…